Latest News | Dr Reddy's Lab Launches Generic Diabetes Medication in US Market

New Delhi, Aug 10 (PTI) Dr Reddy's Laboratories on Thursday said it has launched a generic diabetes medication in the US market.

Also Read | Hike Layoffs: Blockchain Gaming Company Sacks Around 55 People After 28% GST Imposed on Online Gaming.

The drug major has launched Saxagliptin and Metformin Hydrochloride extended-release tablets in the US market, the Hyderabad-based company said in a statement.

The company's product is a therapeutic equivalent generic version of Kombiglyze XR tablets, it added.

Also Read | BPSC Admit Card 2023 to Be Released Today on bpsc.bih.nic.in, Know How to Check.

Dr Reddy's Saxagliptin and Metformin Hydrochloride extended-release tablets are supplied in a strength of 2.5 mg/1000 mg in bottle count of 60 and strengths of 5 mg/500 mg and 5 mg/1000 mg each in bottle counts of 30, the company said.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)